160 related articles for article (PubMed ID: 31394589)
1. A combination therapy of nanoethosomal piroxicam formulation along with iontophoresis as an anti-inflammatory transdermal delivery system for wound healing.
Kazemi M; Mombeiny R; Tavakol S; Keyhanvar P; Mousavizadeh K
Int Wound J; 2019 Oct; 16(5):1144-1152. PubMed ID: 31394589
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: An ex vivo study.
Mombeiny R; Tavakol S; Kazemi M; Mehdizadeh M; Hasanzadeh A; Karimi Babaahmadi M; Abedi A; Keyhanvar P
IET Nanobiotechnol; 2021 Dec; 15(9):710-718. PubMed ID: 34694760
[TBL] [Abstract][Full Text] [Related]
3. Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats.
Teaima M; Abdelmonem R; Adel YA; El-Nabarawi MA; El-Nawawy TM
Drug Des Devel Ther; 2021; 15():4603-4614. PubMed ID: 34785889
[TBL] [Abstract][Full Text] [Related]
4. Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery.
Qindeel M; Ahmed N; Sabir F; Khan S; Ur-Rehman A
Drug Dev Ind Pharm; 2019 Apr; 45(4):629-641. PubMed ID: 30633578
[TBL] [Abstract][Full Text] [Related]
5. Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4.
Fu X; Shi Y; Wang H; Zhao X; Sun Q; Huang Y; Qi T; Lin G
Int J Nanomedicine; 2019; 14():9275-9284. PubMed ID: 31819429
[TBL] [Abstract][Full Text] [Related]
6. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
[TBL] [Abstract][Full Text] [Related]
7. Iontophoresis for the cutaneous delivery of nanoentraped drugs.
Andrade JFM; Cunha-Filho M; Gelfuso GM; Gratieri T
Expert Opin Drug Deliv; 2023 Jun; 20(6):785-798. PubMed ID: 37119173
[TBL] [Abstract][Full Text] [Related]
8. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
9. Nanovesicle Formulation Enhances Anti-inflammatory Property and Safe Use of Piroxicam.
Mbah C; Ogbonna J; Nzekwe I; Ugwu G; Ezeh R; Builders P; Attama A; Adikwu M; Ofoefule S
Pharm Nanotechnol; 2021; 9(3):177-190. PubMed ID: 33511937
[TBL] [Abstract][Full Text] [Related]
10. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study.
Mohammed MI; Makky AM; Teaima MH; Abdellatif MM; Hamzawy MA; Khalil MA
Drug Deliv; 2016 Jun; 23(5):1558-64. PubMed ID: 25726990
[TBL] [Abstract][Full Text] [Related]
12. Exploration of Nanoethosomal Transgel of Naproxen Sodium for the Treatment of Arthritis.
Anjum F; Zakir F; Verma D; Aqil M; Singh M; Jain P; Mirza MA; Anwer MK; Iqbal Z
Curr Drug Deliv; 2020; 17(10):885-897. PubMed ID: 32713340
[TBL] [Abstract][Full Text] [Related]
13. Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats.
Bawazeer S; El-Telbany DFA; Al-Sawahli MM; Zayed G; Keed AAA; Abdelaziz AE; Abdel-Naby DH
Drug Deliv; 2020 Dec; 27(1):1218-1230. PubMed ID: 32772730
[TBL] [Abstract][Full Text] [Related]
14. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
15. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
16. Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride.
Patel N; Jain S; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):442-57. PubMed ID: 24467234
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs.
Pereira RO; Pelisson E Silva TCC; de Oliveira Ferreira A; Brandao MAF; Raposo NRB; Polonini HC
Curr Drug Deliv; 2017; 14(4):516-520. PubMed ID: 27557671
[TBL] [Abstract][Full Text] [Related]
18. Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation.
Abdel Messih HA; Ishak RA; Geneidi AS; Mansour S
Drug Dev Ind Pharm; 2017 Jun; 43(6):958-971. PubMed ID: 28121196
[TBL] [Abstract][Full Text] [Related]
19. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
[TBL] [Abstract][Full Text] [Related]
20. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
